R. Donald Harvey
PharmD, BCOP, FCCP, FHOPA
At Winship Cancer Institute, Dr. Harvey serves as director of the Phase I Clinical Trials Unit, and as medical director of the Clinical Trials Office.
Specialty
Dr. Harvey has established an active clinical pharmacology research program in cancer at Emory with the goal of using pharmacokinetic, pharmacodynamic, and other tools to improve individualization of therapy and clinical outcomes.
Titles and Roles
- Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Professor, Department of Pharmacology and Chemical Biology
- Emory University School of Medicine
- Director, Phase I Clinical Trials Program
- Winship Cancer Institute of Emory University
- Medical Director, Clinical Trials Office
- Winship Cancer Institute of Emory University
- Oncology Pharmacist
- Phase I Clinical Trials Unit
- Research Program
- Discovery and Developmental Therapeutics
Biography
R. Donald Harvey, PharmD, is Professor in the Department of Hematology and Medical Oncology with a joint appointment in the Department of Pharmacology and Chemical Biology at Emory University School of Medicine. A board certified oncology pharmacist, Dr. Harvey serves as director of Winship Cancer Institute's Phase I Clinical Trials Unit. He also serves as Medical Director of Winship's Clinical Trials Office, where he works to ensure the quality and compliance of clinical research practices at all Winship locations. He is a Fellow of the American College of Clinical Pharmacy and a Fellow of the Hematology/Oncology Pharmacy Association.
Dr. Harvey has established an active clinical pharmacology research program in cancer at Emory with the goal of using pharmacokinetic, pharmacodynamic, and other tools to improve individualization of therapy and clinical outcomes. An active principal and co-investigator on multiple trials, he also consults on experimental design of preclinical and clinical studies with a focus on optimizing correlative measures. Specific areas of research interest include agent tolerability and disposition in renal and hepatic impairment, effects of novel immunotherapeutics on hepatic metabolism, and use of therapeutic drug monitoring for anticancer agents.
Dr. Harvey is also active nationally and internationally in several cancer and pharmacology professional organizations. He is also a past president of the Hematology and Oncology Pharmacy Association, an international professional organization.
Education
Dr. Harvey obtained his BS Pharmacy and Doctor of Pharmacy degrees at the University of North Carolina at Chapel Hill (UNC). He completed subsequent training at the University of Kentucky Medical Center and School of Pharmacy and specialized in Hematology/Oncology at UNC, where he was on staff and faculty for 8 years prior to coming to Grady Hospital in Atlanta where he served as a clinical specialist in hematology and oncology and director of the hematology and oncology residency program.
Research
Dr. Harvey's research interests include the clinical application of pharmacokinetic, pharmacodynamic, and pharmacogenomic data to patient care.
Below is a listing of current federal grants for the above principal investigator.
GrantNumber Title
Publications
Dr. Harvey is widely published in peer-reviewed journals.
Publications Publication Date
Awards
Select awards and honors for Dr. Harvey include:
- Award of Excellence, Hematology/Oncology Pharmacy Association (HOPA), 2018
- James R. Eckman Award for Teaching Excellence, Emory School of Medicine Hematology and Medical Oncology Fellowship Program, 2014